Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program
SAN DIEGO, July 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious...